"Ubiquinone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lipid-soluble benzoquinone which is involved in ELECTRON TRANSPORT in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.
Descriptor ID |
D014451
|
MeSH Number(s) |
D02.806.250.900 D08.211.935
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ubiquinone".
Below are MeSH descriptors whose meaning is more specific than "Ubiquinone".
This graph shows the total number of publications written about "Ubiquinone" by people in this website by year, and whether "Ubiquinone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2017 | 3 | 4 | 7 |
2018 | 6 | 4 | 10 |
2019 | 3 | 4 | 7 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Ubiquinone" by people in Profiles.
-
Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population. Elife. 2021 07 27; 10.
-
COVID-19, Coenzyme Q10 and Selenium. Adv Exp Med Biol. 2021; 1327:161-168.
-
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia. Inflamm Res. 2021 Feb; 70(2):159-170.
-
Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol. 2020 12; 142:111147.
-
Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney. Biomed Pharmacother. 2020 Oct; 130:110627.
-
Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19. Med Hypotheses. 2020 Nov; 144:110161.
-
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein Cell. 2020 10; 11(10):723-739.
-
Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19? Bratisl Lek Listy. 2020; 121(11):775-778.
-
Reclassification of 'Polyangium brachysporum' DSM 7029 as Schlegelella brevitalea sp. nov. Int J Syst Evol Microbiol. 2019 Sep; 69(9):2877-2883.
-
The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial. Nutr Neurosci. 2021 Apr; 24(4):317-326.